ADM Korea Announces Niclosamide-based Metabolic Anticancer Drug’s First Clinical Trial Target as ‘Prostate Cancer Patients Resistant to Hormone Therapy’
IND for clinical study for combination therapy with hormone therapy in prostate cancer patients to be submitted in August, 2024. Niclosamide-based metabolic anticancer drug aims to block signaling pathways that allow cancer cells to evade anticancer effects, potentially solving the issue of drug resistance. SEOUL, South Korea, July 11, 2024...
Official Swiss delegation experiences new frontiers in art tech at HKBU
HONG KONG, July 11, 2024 /PRNewswire/ -- A senior Swiss delegation led by Mr Guy Parmelin, Swiss Federal Councillor and Head of the Federal Department of Economic Affairs, Education and Research, visited Hong Kong Baptist University (HKBU) on 5 July. The delegation was able to partake in the premiere of the terapixel scale digital version of the Swiss national treasure painting, The Panorama...
Borsch Med Launches Ikigai Health Campaign with Zeria’s Chondro Max
Community Outreach Campaign Champions Healthy Lifestyle for Healthy Joints SINGAPORE, July 11, 2024 /PRNewswire/ -- Borsch Med Pte Ltd (BM), a leading Health and Nutrition company based in Singapore, and operated and managed by professionals in Goh Joo Hin Pte Ltd (GJH), launched the "Enjoy Your Life with IKIGAI – a reason for being" campaign. This community outreach effort focuses on healthy ageing and joint...
Medit Appoints Han Ryu as CEO, Focusing on Customer-Centric Innovation
SEOUL, South Korea, July 11, 2024 /PRNewswire/ -- Medit, a global leader in dental 3D scanners and digital dentistry solutions, has appointed Han Ryu as its new CEO. Ryu brings with him over three decades of senior management experience in global medical device and healthcare companies, including prominent roles at Siemens Healthineers, Qorvo...
Telix Welcomes CMS Proposal to Improve Payment for Specialised Diagnostic Radiopharmaceuticals
MELBOURNE, Australia, July 11, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today welcomes proposed changes announced by the Centers for Medicare & Medicaid Services (CMS) for the Hospital Outpatient Prospective Payment System (OPPS) rule to improve payments for diagnostic radiopharmaceuticals for Medicare patients in the United States (U.S.),...
Kangsters Unveils Revolutionary Treadmills at Rollettes Experience 2024: Celebrating Innovation and Empowerment
LOS ANGELES, July 11, 2024 /PRNewswire/ -- Kangsters, the pioneering South Korean adaptive tech startup, proudly announces its participation in the Rollettes Experience 2024. This renowned event, now celebrating its 11th anniversary, will be held from July 11-14 at the Sheraton Hotel in Los Angeles, CA. Known as the world's largest event for women and girls with disabilities, the...
Eligo Publishes in Nature a Landmark Study That Unlocks Genome Editing of Bacteria in the Gut
PARIS, July 10, 2024 /PRNewswire/ -- For the first time, a team of scientists at Eligo has demonstrated it was possible to genetically modify bacteria with nearly 100% efficiency directly in the gut of animals. This work provides scientists with a novel strategy to better understand how genes from our microbiome drive disease,...
iHerb® Unveils New Global, Online Distribution Partnership with The Vitamin Shoppe®
Proprietary supplement brands, including The Vitamin Shoppe®, Vthrive The Vitamin Shoppe®, BodyTech® and BodyTech® Elite, are now available in over 180 countries via iHerb IRVINE, Calif., July 10, 2024 /PRNewswire/ -- Today marks a significant milestone in the health and wellness industry as iHerb, one of the world's leading e-commerce retailers for vitamins, minerals, supplements and other health and wellness...
Snorles GenioFlex: The Innovative Daytime Solution for Snoring Management Now Launched on Indiegogo
HONG KONG, July 10, 2024 /PRNewswire/ -- Snorles, a leading innovator in sleep technology, is excited to announce the launch of its latest product, GenioFlex. Snorles created to address snoring issues and promote overall health and well-being, GenioFlex offers a fresh approach to managing snoring without the need for intrusive nighttime devices. Snorles GenioFlex distinguishes itself...
AIRS Medical Secures $20M in Series C Funding to Advance AI-Powered Preventive Healthcare Solutions
SEOUL, South Korea, July 10, 2024 /PRNewswire/ -- AIRS Medical, a pioneering force in artificial intelligence (AI) and robotics for healthcare applications, today announced the completion of its Series C funding round, securing $20 million from seven institutional investors in Korea. The investment, led by BSK Investment and Shinyoung Securities, underscores confidence...















